Results 161 to 170 of about 258,704 (366)

Causal machine learning for heterogeneous treatment effects in the presence of missing outcome data [PDF]

arXiv
When estimating heterogeneous treatment effects, missing outcome data can complicate treatment effect estimation, causing certain subgroups of the population to be poorly represented. In this work, we discuss this commonly overlooked problem and consider the impact that missing at random (MAR) outcome data has on causal machine learning estimators for ...
arxiv  

Hormone replacement therapy Cardioprotective effect is genuine [PDF]

, 1994
Mark Duncan, J. Court Stevenson, M Baum, Ward Posthuma, R. G. J. Westendorp, Jan P. Vandenbroucke, Abioye Ai'r, G Y H Lip, D G Beevers   +8 more
openalex   +1 more source

Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer

Advanced Science, EarlyView.
Breast cancer cells undergo metabolic and transcriptomic reprogramming to support aberrant cell proliferation. Their mitochondria rely on the transfer of phosphatidylcholine from the endoplasmic reticulum to their membranes by STARD7, a candidate upregulated in breast cancer, to be functional.
Ewelina Dondajewska, Paula Allepuz‐Fuster, Chloé Maurizy, Alexandre Hego, Sandra Ormenese, Quentin Lion, Arnaud Blomme, Pierre Close, Arnaud Lavergne, Latifa Karim, Marc Thiry, Ivan Nemazanyy, Roopesh Krishnankutty, Jair Marques Jr, Alex von Kriegsheim, Nathaniel F. Henneman, Ganna Panasyuk, Kateryna Shostak, Alain Chariot   +18 more
wiley   +1 more source

Long‐term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

BJS (British Journal of Surgery), EarlyView., 2020
This long‐term follow‐up study determined survival rates in a Swedish national cohort of 417 patients with breast cancer who all had neoadjuvant systemic therapy (NAST). Sentinel lymph node biopsy (SLNB) was performed before NAST in clinically node‐negative and after NAST in clinically node‐positive patients.
L. Zetterlund, F. Celebioglu, T. Hatschek, J. Frisell, J. de Boniface   +4 more
wiley   +1 more source

91217900 Hormone replacement therapy in general practice: A survey of doctors in the MRC's general practice research framework [PDF]

, 1992
H Wilkes, T. W. Meade
openalex   +1 more source

Hormone Replacement Therapy [PDF]

Journal of the Royal Society of Medicine, 1979
openaire   +3 more sources

Microbial Biosensor for Sensing and Treatment of Intestinal Inflammation

Advanced Science, EarlyView.
The engineered calprotectin biosensor detects gut inflammation, processes the signal through genetic regulation, and responds by expressing the reporter sfGFP and the therapeutic protein secIL10. This dual functionality enables the engineered biosensor not only to sense but also to mitigate gut inflammation, highlighting its potential for disease ...
Duolong Zhu, Jeffrey Galley, Jason Pizzini, Elena Musteata, Martin V. Douglas, Walter J. Chazin, Eric P. Skaar, Jeffrey J. Tabor, Robert A. Britton   +8 more
wiley   +1 more source

Changes in LDL and HDL cholesterol levels with continuous combined estrogen and desogestrel hormone replacement therapy [PDF]

, 1994

openalex   +1 more source

Women's decision making process about hormone replacement therapy in the New Zealand context : a thesis presented in partial fulfilment of the requirements for the degree of Master of Arts in Psychology at Massey University [PDF]

, 2003
Some Appendix in MaoriThe transitional time of menopause has differential meanings for mid-aged women around the world. The medicalisation of menopause has resulted in the increasing promotion of hormone replacement therapy (HRT) both to alleviate ...
Radford, Wendy Lena
core  

Postmenopausal hormone replacement therapy

Ceylon Medical Journal, 2011
We need to clarify our practice guidelines and open a dialogue with our patients DOI: http://dx.doi.org/10.4038/cmj.v49i3.3242 Ceylon Medical Journal 2004; 49: 73 ...
openaire   +4 more sources